Recombinant Human TYK2 Protein (556-1187), N-DYKDDDDK-tagged

Cat.No. : TYK2-02H
Product Overview : Human TYK2, catalytic/pseudo-kinase domain [556-1187(end) amino acids of accession number NP_003322.3] was expressed as N-terminal DYKDDDDK tagged, biotinylated protein (76 kDa) using baculovirus expression system. The protein was purified by using DYKDDDDK tag antibody agarose.
  • Specification
  • Gene Information
  • Related Products
  • Download
Description : This gene encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families. This protein associates with the cytoplasmic domain of type I and type II cytokine receptors and promulgate cytokine signals by phosphorylating receptor subunits. It is also a component of both the type I and type III interferon signaling pathways. As such, it may play a role in anti-viral immunity. A mutation in this gene has been associated with Immunodeficiency 35.
Source : Insect cells
Species : Human
Molecular Mass : 76 kDa
Protein Length : 556-1187
Purity : 85%
Storage : Store at -80 centigrade.
Avoid repeating freeze-thaws.
Storage Buffer : 50 mM Tris-HCl, 150 mM NaCl, 0.05% Brij35, 1 mM DTT, 10% glycerol, pH7.5
Gene Name : TYK2 tyrosine kinase 2 [ Homo sapiens (human) ]
Official Symbol : TYK2
Synonyms : TYK2; tyrosine kinase 2; JTK1; IMD35; non-receptor tyrosine-protein kinase TYK2; EC
Gene ID : 7297
mRNA Refseq : NM_003331
Protein Refseq : NP_003322
MIM : 176941
UniProt ID : P29597

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.


  • Q&As
  • Reviews

Q&As (5)

Ask a question
Could TYK2 inhibitors have applications beyond autoimmune diseases? 05/14/2022

Yes, TYK2 inhibitors might have potential in treating certain cancers and possibly other inflammatory conditions beyond autoimmune diseases.

What are the potential benefits of targeting TYK2 in treating autoimmune diseases? 02/09/2021

TYK2 inhibition can potentially reduce inflammation and modulate immune responses without suppressing the entire immune system, unlike some other treatments.

Are there any clinical trials ongoing or completed regarding TYK2 inhibitors? 05/10/2020

Yes, there are several clinical trials evaluating the efficacy and safety of TYK2 inhibitors in various autoimmune diseases.

How do TYK2 inhibitors differ from other treatments for autoimmune diseases? 01/31/2018

TYK2 inhibitors are more targeted, aiming to interfere with specific signaling pathways involved in the immune response compared to broad immunosuppressants.

How are TYK2 inhibitors administered to patients? 11/17/2017

Depending on the formulation, TYK2 inhibitors can be administered orally or through injections.

Customer Reviews (3)

Write a review

    Their expertise in protein production and purification ensures the delivery of a high-quality product that consistently performs well in my experiments.


      They are readily available to address any concerns or questions and supply valuable resources to assist in experimental design and optimization.


        Should I encounter any challenges or require technical assistance, the manufacturer provides prompt and knowledgeable support.

        Ask a Question for All TYK2 Products

        Required fields are marked with *

        My Review for All TYK2 Products

        Required fields are marked with *


        Inquiry Basket


        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /
        • Service lnquiry:

        Stay Updated on the Latest Bioscience Trends